Macrophage activation and differentiation signals regulate schlafen-4 gene expression: evidence for Schlafen-4 as a modulator of myelopoiesis.
BACKGROUND
The ten mouse and six human members of the Schlafen (Slfn) gene family all contain an AAA domain. Little is known of their function, but previous studies suggest roles in immune cell development. In this report, we assessed Slfn regulation and function in macrophages, which are key cellular regulators of innate immunity.


RESULTS
Multiple members of the Slfn family were up-regulated in mouse bone marrow-derived macrophages (BMM) by the Toll-like Receptor (TLR)4 agonist lipopolysaccharide (LPS), the TLR3 agonist Poly(I∶C), and in disease-affected joints in the collagen-induced model of rheumatoid arthritis. Of these, the most inducible was Slfn4. TLR agonists that signal exclusively through the MyD88 adaptor protein had more modest effects on Slfn4 mRNA levels, thus implicating MyD88-independent signalling and autocrine interferon (IFN)-β in inducible expression. This was supported by the substantial reduction in basal and LPS-induced Slfn4 mRNA expression in IFNAR-1⁻/⁻ BMM. LPS causes growth arrest in macrophages, and other Slfn family genes have been implicated in growth control. Slfn4 mRNA levels were repressed during macrophage colony-stimulating factor (CSF-1)-mediated differentiation of bone marrow progenitors into BMM. To determine the role of Slfn4 in vivo, we over-expressed the gene specifically in macrophages in mice using a csf1r promoter-driven binary expression system. Transgenic over-expression of Slfn4 in myeloid cells did not alter macrophage colony formation or proliferation in vitro. Monocyte numbers, as well as inflammatory macrophages recruited to the peritoneal cavity, were reduced in transgenic mice that specifically over-expressed Slfn4, while macrophage numbers and hematopoietic activity were increased in the livers and spleens.


CONCLUSIONS
Slfn4 mRNA levels were up-regulated during macrophage activation but down-regulated during differentiation. Constitutive Slfn4 expression in the myeloid lineage in vivo perturbs myelopoiesis. We hypothesise that the down-regulation of Slfn4 gene expression during macrophage differentiation is a necessary step in development of this lineage.
The University of Queensland, Institute for Molecular Bioscience, Queensland, Australia.
Wendy J
WJ
van Zuylen
Valerie
V
Garceau
Adi
A
Idris
Kate
K
Schroder
Katharine M
KM
Irvine
Jane E
JE
Lattin
Dmitry A
DA
Ovchinnikov
Andrew C
AC
Perkins
Andrew D
AD
Cook
John A
JA
Hamilton
Paul J
PJ
Hertzog
Katryn J
KJ
Stacey
Stuart
S
Kellie
David A
DA
Hume
Matthew J
MJ
Sweet
D000818:Animals; D002352:Carrier Proteins / Q000235:genetics* / Q000502:physiology; D002453:Cell Cycle / Q000276:immunology; D005786:Gene Expression Regulation / Q000276:immunology; D007113:Immunity, Innate; D008262:Macrophage Activation; D008264:Macrophages / Q000166:cytology* / Q000276:immunology; D051379:Mice; D008822:Mice, Transgenic; D038042:Myelopoiesis; D012333:RNA, Messenger / Q000032:analysis; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology / Q000502:physiology
D002352:Carrier Proteins; D012333:RNA, Messenger; C559915:schlafen-4 protein, mouse
Ann Rheum Dis. 1997 Jun;56(6):364-8
9227165
J Biol Chem. 2007 May 25;282(21):15319-23
17395581
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4936-41
15044701
Infect Immun. 2006 May;74(5):2787-802
16622216
Cell. 2008 Feb 22;132(4):631-44
18295580
Nat Genet. 2006 Jun;38(6):626-35
16645617
J Gen Virol. 2007 Jun;88(Pt 6):1667-1676
17485525
Immunity. 1998 Nov;9(5):657-68
9846487
Immunobiology. 2006;211(6-8):511-24
16920490
J Leukoc Biol. 2005 Jul;78(1):9-13
15774547
J Leukoc Biol. 2008 Feb;83(2):430-3
17971498
Biochem Biophys Res Commun. 2009 Oct 30;388(4):752-6
19703412
FASEB J. 2006 Sep;20(11):1921-3
16877523
Nat Med. 2005 Nov;11(11):1180-7
16208318
J Cell Physiol. 1985 Mar;122(3):362-9
2981895
Annu Rev Biochem. 1987;56:727-77
2441659
Blood. 2008 Oct 15;112(8):3412-24
18663149
Arthritis Res. 2000;2(3):189-202
11094428
Dev Comp Immunol. 2004 May 3;28(5):509-54
15062647
J Immunol. 2008 Jul 15;181(2):1232-44
18606677
Infect Immun. 2005 Jan;73(1):532-45
15618193
Arthritis Res Ther. 2006;8(4):R100
16805906
Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9784-8
1409699
J Inflamm. 1998;48(2):67-83
9656143
J Leukoc Biol. 2010 Mar;87(3):451-6
19996332
J Leukoc Biol. 2009 Feb;85(2):278-88
19004987
Gene. 2009 Nov 1;447(1):1-11
19619625
Br J Haematol. 1990 Feb;74(2):138-45
2180468
J Immunol. 1996 Apr 1;156(7):2553-7
8786318
Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G955-62
19228883
J Neuroimmunol. 2005 May;162(1-2):103-11
15833365
Nat Immunol. 2006 Apr;7(4):375-81
16491077
Int Immunol. 2004 Oct;16(10):1535-48
15351786
Mol Cell Biol. 2004 Jan;24(2):741-56
14701746
J Leukoc Biol. 2010 May;87(5):815-22
20123678
J Biol Chem. 2009 Sep 11;284(37):25051-64
19592487
Biochem Biophys Res Commun. 2008 May 23;370(1):62-6
18355440
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13453-8
14597717
Nat Immunol. 2010 Apr;11(4):335-43
20190759
Science. 2009 Feb 20;323(5917):1057-60
19131592
Curr Opin Immunol. 2006 Feb;18(1):49-53
16338128
J Biol Chem. 2005 Sep 2;280(35):30723-34
15946944
Genomics. 2010 Jun;95(6):328-38
20211243